{"job_id": "c105eb7f-f10d-4f47-8a5a-93d85d7a96ee", "brochure_id": "c105eb7f-f10d-4f47-8a5a-93d85d7a96ee", "brochure_name": "BTM Brochure_22 Sept.pdf", "status": "completed", "results": [{"statement": "Epidemiology. Breast cancer remains the most frequently diagnosed cancer in women worldwide, with incidence rates continuing to rise. 2.3 million new breast cancer cases were diagnosed globally in 2022, with 42.9% of them in Asia.", "reference_no": "1", "reference": "Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer; 2024. Accessed May 21, 2025. https://gco.iarc.fr/today", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 1.Ferlay J,2025.pdf: Asia 985 817 42.9%", "validation_result": "Supported", "page_location": "Page 1, under the Incidence pie chart", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Epidemiology. Asian women are diagnosed at younger ages (median 40-50 yrs.) compared to Western women (60-70 yrs.).", "reference_no": "2", "reference": "Lim YX, Lim ZL, Ho PJ, Li J. Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives. Cancers (Basel). 2022 Aug30;14(17):4218.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 2.Lim YX, 2022.pdf: Breast cancer strikes Asian women earlier than it does Western women [2,3].|In Asian countries, the peak age is between 40 and 50 years, while in Western countries, it is between 60 and 70 years [2,3].", "validation_result": "Supported", "page_location": "Page 2, section 1.2", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Epidemiology. The Asia-Pacific (APAC) region recorded 985,400 new cases, and 315,100 deaths in 2022, predicted to reach 1.4 million cases by 2050.", "reference_no": "3", "reference": "Fu M, Peng Z, Wu M, Lv D, Li Y, Lyu S. Current and future burden of breast cancer in Asia: A GLOBOCAN data analysis for 2022 and 2050. The Breast. 2025;79:103835. doi:https://doi.org/10.1016/ j.breast.2024.103835", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 3.Fu M,2024.pdf: In Asia, an estimated 985.4 thousand new cases and 315.1 thousand deaths were reported, corresponding to age-standardized incidence and mortality rates of 34.3 and 10.5 per 100,000, respectively.|China and India are the leading contributors to both new cases and deaths, with projections indicating that by 2050, around 1.4 million new breast cancer cases and 0.5 million deaths are expected to occur in Asia.", "validation_result": "Supported", "page_location": "Page 2, Results section", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Epidemiology. 63.4% of breast cancer cases are diagnosed at stage I-II in high-income Asian countries.", "reference_no": "4", "reference": "Park KH, Loibl S, Sohn J, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer. ESMO Open.2024;9(5):102974-102974. doi:https://doi.org/10.1016/j.esmoop.2024.102974", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 4.Park KH,2024.pdf: For example, 63.4% of breast cancer diagnoses in the high-income regions of Asia were stage I and II compared with 33.6% and 43% in low- and LMICs, respectively.", "validation_result": "Supported", "page_location": "Page 3, paragraph 2", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Epidemiology. Breast cancer in young women is often more aggressive with a high recurrence risk, requiring regular follow-ups.", "reference_no": "5", "reference": "Beadle BM, Woodward WA, Buchholz TA. The Impact of Age on Outcome in Early-Stage Breast Cancer. Seminars in Radiation Oncology. 2011;21(1):26-34. doi:https://doi.org/10.1016/j.semradonc.2010.09.001", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 5.Beadle BM,2011.pdf: Numerous studies have shown very different breast cancer outcomes based on patient age; younger women typically have more aggressive tumors that are more likely to recur both locoregionally and distantly, and older women more commonly have less aggressive disease.", "validation_result": "Supported", "page_location": "Page 1, Abstract", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Advances in Imaging Detecting Smaller Lesions. Advanced imaging technologies like high-resolution stereotactic/mammographic imaging, ultrasound and MRI aid early detection of cancer by identifying tumors at small sizes (often <5mm). After biopsy, these small lesions may disappear visually making it difficult to follow up after the biopsy procedure.", "reference_no": "6", "reference": "Shah AD, Mehta AK, Talati N, Brem R, Margolies LR. Breast tissue markers: Why? What's out there? How do I choose?. Clin Imaging. 2018;52:123-136.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 6.Shah A, 2018.pdf: Image detection of non-palpable breast lesions has fueled the development of image-guided biopsy and localization.|Minimally invasive image-guided breast core biopsy allows for a reliable pathologic diagnosis and, in clinical practice, has nearly replaced surgical excision for initial tissue evaluation [1].|As clinical practices have shifted toward image-guided biopsy, tissue marker placement to identify the biopsy site has become a vital component of the procedure.", "validation_result": "Supported", "page_location": "Page 1, Introduction", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Advances in Imaging Detecting Smaller Lesions. MRI and multimodal imaging are particularly beneficial in detecting microlesions.", "reference_no": "6", "reference": "Shah AD, Mehta AK, Talati N, Brem R, Margolies LR. Breast tissue markers: Why? What's out there? How do I choose?. Clin Imaging. 2018;52:123-136.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 6.Shah A, 2018.pdf: Image detection of non-palpable breast lesions has fueled the de-velopment of image-guided biopsy and localization.|Minimally invasive image-guided breast core biopsy allows for a reliable pathologic diag-nosis and, in clinical practice, has nearly replaced surgical excision for initial tissue evaluation [1].", "validation_result": "Supported", "page_location": "Page 1, Introduction", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Advances in Imaging Detecting Smaller Lesions. Second-look ultrasound and MRI-guided biopsies further improve detection.", "reference_no": "6", "reference": "Shah AD, Mehta AK, Talati N, Brem R, Margolies LR. Breast tissue markers: Why? What's out there? How do I choose?. Clin Imaging. 2018;52:123-136.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 6.Shah A, 2018.pdf: Image detection of non-palpable breast lesions has fueled the de-velopment of image-guided biopsy and localization.|Minimally invasive image-guided breast core biopsy allows for a reliable pathologic diag-nosis and, in clinical practice, has nearly replaced surgical excision for initial tissue evaluation [1].|Clip placement is particularly important for inter-modality corre-lation when a second look ultrasound for a suspicious MRI-detected lesion results in ultrasound-guided biopsy of a presumed sonographic correlate [13].", "validation_result": "Supported", "page_location": "Page 1, Introduction; Page 2, Inter-modality correlation", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Unmet Challenges in Modern Breast Cancer Management. When multiple lesions are detected on one side of the breast, it becomes challenging to differentiate one from another.", "reference_no": "6", "reference": "Shah AD, Mehta AK, Talati N, Brem R, Margolies LR. Breast tissue markers: Why? What's out there? How do I choose?. Clin Imaging. 2018;52:123-136.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 6.Shah A, 2018.pdf: When multiple lesions are found in a single breast in a patient with a known cancer, placement of uniquely shaped tissue markers at each site allows for assessment of extent of disease and differentiation between benign and malignant sites.", "validation_result": "Supported", "page_location": "Page 3, Section 2.3 Extent of disease assessment", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Unmet Challenges in Modern Breast Cancer Management. Mismatches between imaging modalities can lead to missed diagnoses or repeat biopsies.", "reference_no": "6", "reference": "Shah AD, Mehta AK, Talati N, Brem R, Margolies LR. Breast tissue markers: Why? What's out there? How do I choose?. Clin Imaging. 2018;52:123-136.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 6.Shah A, 2018.pdf: The biopsy clip serves a critical role in correlating findings between imaging modalities. | It is common for abnormalities detected on mammography or MRI to undergo further workup with targeted ultrasound. | However, whenever a suspicious lesion is identified with one modality and another modality is used for biopsy, there is a possibility that the sampled lesion does not correspond to the originally identified suspicious target.", "validation_result": "Supported", "page_location": "Page 2, Section 2.2 Inter-modality correlation", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Unmet Challenges in Modern Breast Cancer Management. NAC often reduces tumors to small, deep, non-palpable lesions, making precise localization difficult during surgery.", "reference_no": "6.7", "reference": "", "matched_paper": "None", "matched_evidence": "No matching reference PDF was found for the extraction: 6.7", "validation_result": "Reference Missing", "page_location": "N/A", "confidence_score": 0.0, "matching_method": "Reference Filter", "analysis_summary": "Validation skipped: Reference Missing", "confidence_band": "LOW"}, {"statement": "Recent Trends in Breast Cancer Management. NAC, administered before surgery to shrink tumors, has become a key approach in the management of locally advanced breast cancer. Increasingly, NAC is also used in early-stage breast cancer to:", "reference_no": "7", "reference": "P Y, Christina EP, Ramaswami S, Sl H, Natarajan P. Comparative Evaluation of USG-Guided Single Tissue Marker Versus Multiple Tissue Marker Placements in Breast Malignancy Patients Undergoing Neoadjuvant Chemotherapy for Tumor Localization. Cureus.2024;16(7):e65355.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 7.P Y Christina,2024.pdf: The advent of neoadjuvant chemotherapy (NAC) has revolutionized the treatment paradigm for locally advanced breast cancer. | NAC can downstage tumors, making them amenable to breast-conserving surgery (BCS) rather than mastectomy, and allows for the assessment of tumor response to therapy [2].", "validation_result": "Supported", "page_location": "Page 2, Introduction section", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Breast Tissue Markers: A Key to Precision in Cancer Care. A breast biopsy marker is a small, surgical-grade device placed at the biopsy site under image guidance. It enables clear identification and visualization of abnormal breast tissue, axillary lesions, and lymph nodes, ensuring accurate clinical follow-up and treatment planning.", "reference_no": "8", "reference": "Martin EA,Chauhan N, Dhevan V, et al. Current status of biopsy markers for the breast in clinical settings. Expert Rev Med Devices. 2022;19(12):965-975.9. Alshafeiy TI, Matich A, Rochman CM, Harvey JA. Advantages and Challenges of Using Breast Biopsy Markers. J Breast Imaging. 2022;4(1):78-95.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 8.Martin ,2022.pdf: A breast biopsy marker or breast marker is a small device made up of surgical-grade material such as titanium or stainless steel that is placed in the area where biopsy tissue is removed by way of image guidance.|The use of breast markers has become a key component of patient management [4].|Breast biopsy markers are easy to recognize and pinpoint by stereotactic (S) and ultrasound (US) guidance, mammogram, and magnetic resonance imaging (MRI) techniques [6].|Breast biopsy marker enables physicians to efficiently identify and pinpoint tissues that have already been suspected and ana-lyzed for the possibility of cancer [16].|Breast biopsy marker enables identification and visualization of abnormal breast tissue, breast and axilla legions, and lymph nodes under clinical follow-up care.", "validation_result": "Supported", "page_location": "Page 2, Introduction | Page 2, Introduction | Page 2, Introduction | Page 3, Localization for surgery | Page 3, Article highlights", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Overcoming Challenges in Detection and Treatment. Ensures precise marking of biopsy sites to aid future imaging and interventions, while differentiating new from previously biopsied tissue and preventing repeat biopsies.", "reference_no": "8.9", "reference": "", "matched_paper": "None", "matched_evidence": "No matching reference PDF was found for the extraction: 8.9", "validation_result": "Reference Missing", "page_location": "N/A", "confidence_score": 0.0, "matching_method": "Reference Filter", "analysis_summary": "Validation skipped: Reference Missing", "confidence_band": "LOW"}, {"statement": "Overcoming Challenges in Detection and Treatment. Increases the chances of achieving clear lesion margins (90% with markers vs. 31-62% without), ensuring targeted excision.", "reference_no": "8", "reference": "Martin EA,Chauhan N, Dhevan V, et al. Current status of biopsy markers for the breast in clinical settings. Expert Rev Med Devices. 2022;19(12):965-975.9. Alshafeiy TI, Matich A, Rochman CM, Harvey JA. Advantages and Challenges of Using Breast Biopsy Markers. J Breast Imaging. 2022;4(1):78-95.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 8.Martin ,2022.pdf: For example, during breast surgery, 90% clear lesion margins are achieved when utilizing breast biopsy markers, while only 31-62% clear margins are achieved without a breast marker [3,7-9].", "validation_result": "Supported", "page_location": "Page 2, Introduction", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Overcoming Challenges in Detection and Treatment. Easily identifiable through ultrasound (US), stereotactic (S), mammographic, and MRI guidance for accurate positioning.", "reference_no": "8", "reference": "Martin EA,Chauhan N, Dhevan V, et al. Current status of biopsy markers for the breast in clinical settings. Expert Rev Med Devices. 2022;19(12):965-975.9. Alshafeiy TI, Matich A, Rochman CM, Harvey JA. Advantages and Challenges of Using Breast Biopsy Markers. J Breast Imaging. 2022;4(1):78-95.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 8.Martin ,2022.pdf: Breast biopsy markers are easy to recognize and pinpoint by stereotactic (S) and ultrasound (US) guidance, mammogram, and magnetic resonance imaging (MRI) techniques [6].", "validation_result": "Supported", "page_location": "Page 2, paragraph 5", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Overcoming Challenges in Detection and Treatment. Facilitates multifocal tumor assessment, accurate tissue sampling, and precise marker placement during chemotherapy.", "reference_no": "8", "reference": "Martin EA,Chauhan N, Dhevan V, et al. Current status of biopsy markers for the breast in clinical settings. Expert Rev Med Devices. 2022;19(12):965-975.9. Alshafeiy TI, Matich A, Rochman CM, Harvey JA. Advantages and Challenges of Using Breast Biopsy Markers. J Breast Imaging. 2022;4(1):78-95.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 8.Martin ,2022.pdf: Breast markers are also convenient when assessing the multifocality of a tumor if multiple sites of the breast have been biopsied, and in modality correlation, minimizing repeated biopsies, and in precise marker placement at the beginning and during chemotherapy [3,4].", "validation_result": "Supported", "page_location": "Page 2, paragraph discussing the benefits of breast biopsy markers", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Practical Applications of Breast Tissue Markers. Practical Applications of Breast Tissue Markers", "reference_no": "8,10", "reference": "", "matched_paper": "Multiple PDFs (2/2 support)", "matched_evidence": "- 8.Martin ,2022.pdf: Introduction: A breast biopsy marker is a very small object that is introduced into the breast to serve as\na tissue marker. | The placement of a breast marker following a biopsy or to mark an abnormality in the\nbreast has become standard practice in the clinical setting.\n- 10.Thomassin-naggara2011.pdf: We believe biopsy clip markers should be deployed after all percutaneous interventions.", "validation_result": "Supported", "page_location": "Page 2, Abstract | Page 2, Abstract and Conclusion", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}, {"statement": "Practical Applications of Breast Tissue Markers. To mark the biopsy site ensuring accurate localization for future reference.", "reference_no": "10,11", "reference": "", "matched_paper": "Multiple PDFs (2/2 support)", "matched_evidence": "- 10.Thomassin-naggara2011.pdf: Biopsy clips allow for precise lesion localization, thus minimizing the volume of breast to be resected at the time of surgery.\n- 11.Nurko, 2005.pdf: In such cases a metallic marker is often inserted at the site of the biopsy for future localization.", "validation_result": "Supported", "page_location": "Page 2, paragraph 6 | Abstract, Background", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}, {"statement": "Practical Applications of Breast Tissue Markers. Marker enabled intraoperative ultrasound localization, achieved 90% clear margins (37/41), and significantly reduced positive margins (p < 0.01).", "reference_no": "10,11", "reference": "", "matched_paper": "Multiple PDFs (2/2 support)", "matched_evidence": "- 10.Thomassin-naggara2011.pdf: Centers using this approach report improved outcomes in their surgeries, with clear margins achieved in 87-90% of cases [11, 25]. |While interesting, these results were obtained in small series (41 and 15 patients, respectively) and will need validation in a larger cohort of patients.\n- 11.Nurko, 2005.pdf: Results: A total of 432 records of patients who underwent imaging-guided breast biopsy with placement of Gel Mark Ultra clip were reviewed.|Of these, 63 (15%) patients required definitive surgical intervention, for which 41 cases were localized with ultrasound and assessed for margin clearance.|Clear margins were achieved in 37 (90%) of the 41 cases.|These results are statistically superior (P < .01) to positive margins rates reported in the literature.", "validation_result": "Supported", "page_location": "Page 6, paragraph 1 | Page 1, Abstract section", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}, {"statement": "Neoadjuvant Chemotherapy for Tumor Localization. To mark the tumor before starting NAC for better identification during post-treatment surgery.", "reference_no": "1", "reference": "Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer; 2024. Accessed May 21, 2025. https://gco.iarc.fr/today", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 1.Ferlay J,2025.pdf: [No evidence text provided]", "validation_result": "Not Found", "page_location": "Entire document", "confidence_score": 0.1, "matching_method": "Aggregated (Not Found)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "LOW"}, {"statement": "Other indications. Other indications", "reference_no": "8,10", "reference": "", "matched_paper": "Multiple PDFs (2/2 support)", "matched_evidence": "- 8.Martin ,2022.pdf: [No evidence text provided]\n- 10.Thomassin-naggara2011.pdf: [No evidence text provided]", "validation_result": "Not Found", "page_location": "", "confidence_score": 0.0, "matching_method": "Aggregated (Not Found)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "LOW"}, {"statement": "US-Guided Axillary Node Localization Post-NAC. Presence of right breast cancer and axillary LN metastasis requiring marker insertion before NAC.", "reference_no": "12", "reference": "Kim KE, Ko EY, Han BK, et al. Comparison of the Ultrasound Visibility of Tissue Markers in Metastatic Lymph Nodes after Neoadjuvant Chemotherapy in Patients with Breast Cancer. Diagnostics (Basel). 2022;12(10):2424.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 12. Kim KE,2022.pdf: From March 2020 to August 2021, we inserted tissue markers for histologically proven metastatic axillary lymph nodes in patients with breast cancer scheduled for NAC.", "validation_result": "Supported", "page_location": "Page 2, Materials and Methods, Patients", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "US-Guided Axillary Node Localization Post-NAC. A study documented that breast biopsy clips and point markers enabled 90% tailored axillary surgery (TAS) success with 0% false negatives, ensuring precise lymph node removal.", "reference_no": "13", "reference": "Endo Y, Kotani H, Tamura N, et al. Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy. Breast Cancer. 2024;31(6):1130-1136.14. AGuidelines Detail. NCCN. Published 2020. Accessed May 21, 2025. https://www.nccn.org/guidelines/guidelines-detail?id=1419.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 13. Endo,2024.pdf: TAS was successful in 18 of the 20 patients (90%). | Seven patients underwent TAS and axillary lymph node dissection with a false-negative rate of 0%.", "validation_result": "Supported", "page_location": "Abstract, Results", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "USA and Canada. National Comprehensive Cancer Network\u00b9\u2074 - Encourages to place clips during biopsy of suspicious axillary nodes to guide surgery. In cases with palpable or multiple suspicious nodes, malignancy must be confirmed by FNA or core biopsy with clip placement.", "reference_no": "14", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 14.NCCN breast cancer,2024.pdf: Footnote uu revised: At the time of biopsy of the most suspicious axillary lymph node(s) sampling, a marker elip or tattoe should be placed to allow for identification and removal that the biopsy-positive lymph node has been removed at the time of definitive surgery.|Column 1, last bullet revised: Biopsy + marker elip placement recommended of the most suspicious and/or clinically positive axillary lymph nodes, if not previously done; only the most suspicious node should be marked and retrieved along with SLNs", "validation_result": "Supported", "page_location": "Page 6, BINV-12 and BINV-13", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "USA and Canada. American Cancer Society\u00b9\u2075 - States that a tissue marker (clip) is put into the area where biopsy is done so the exact area can be located for further treatment. The placement is followed by a mammogram to confirm its exact position.", "reference_no": "15", "reference": "American Cancer Society. Core Needle Biopsy of the Breast | Stereotactic Breast Biopsy. www.cancer.org. Published 2022. https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/breast-biopsy/core-needle-biopsy-of-the-breast.html", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 15.American Cancer Society. 2022.pdf: Typically, a tiny tissue marker (also called a clip) is put into the area where the biopsy is done. | This marker will show up on mammograms or other imaging tests so the exact area can be located for further treatment (if needed) or follow up.| Afterwards, the device is removed from the breast, and a biopsy marker (clip) is placed in the area. | Another mammogram is then done to confirm the marker is in the right place.", "validation_result": "Supported", "page_location": "Page 2, under the section 'During the CNB' and 'Stereotactic (mammogram-or tomosynthesis-guided) core needle biopsy'", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "USA and Canada. American Society of Breast Surgeons\u00b9\u2076 - Suggests for placement of a detectable tissue marker into the breast primary and any additional sites of disease as well as any axillary sites.", "reference_no": "16", "reference": "Image-Guided Percutaneous Biopsy of Palpable and Nonpalpable Breast Lesions. https://breastsurgeons.org/docs/statements/Consensus-Guideline-on-Image-Guided-Percutaneous-Biopsy-of-Palpable-and-Nonpalpable -Breast-Lesions.pdf", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 16.Image-Guided Percutaneous.pdf: Place a clip or other marking device at the time of percutaneous biopsy of all suspicious lesions. It helps to confirm appropriate sampling and improves the accuracy of future localization if there is concern the lesion may be completely removed during MIBT or if the patient is to undergo neoadjuvant therapy.", "validation_result": "Supported", "page_location": "Page 3, ASBrS Recommendations, 2. Techniques: c.", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "USA and Canada. Canadian Cancer Society\u00b9\u2077 - Advises the use of a small metal clip to be left in the biopsy site as a marker so the area can be relocated for further treatment.", "reference_no": "17", "reference": "Cancer C. Stereotactic core biopsy. Canadian Cancer Society. Published 2015. https://cancer.ca/en/treatments/ tests-and- procedures/stereotactic-core-biopsy.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 17.Cancer C,2015.pdf: A small metal clip may be left in the site of the biopsy as a marker so the area can be found again easily if more surgery is needed.", "validation_result": "Supported", "page_location": "Page 1, under \"How a stereotactic core biopsy of the breast is done\"", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Europe. European Commission Initiative on Breast Cancer\u00b9\u2078 - Suggests using clip-marking after NCB/VANCB for surgical therapy planning in patients with breast cancer lesions.", "reference_no": "18", "reference": "European guidelines on breast cancer screening and diagnosis | European Commission Initiative on Breast and Colorectal cancer. cancer-screening-and-care.jrc.ec.europa.eu. https://cancer-screening -and-care.jrc.ec.europa.eu/en/ecibc/european-breast-cancer-guidelines", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 18.European guidelines on breast cancer screening and diagnosis.pdf: The ECIBC's Guidelines Development Group (GDG) suggests using clip-marking after needle core biopsy (NCB)/vacuum assisted needle core biopsy (VANCB) for surgical therapy planning in patients with breast cancer lesions.", "validation_result": "Supported", "page_location": "Page 25, section 11.1", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Europe. European Society of Medical Oncology\u00b9\u2079 - Recommends marking the tumor site with clips to facilitate an accurate planning of the radiation boost field and surgery precision.", "reference_no": "19", "reference": "Loibl S, Varga A, Bachelot T, et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up\u2020. Annals of Oncology. 2023;35(2).", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 19.Loibl S, 2023.pdf: Marking the tumour bed with clips facilitates an accurate planning of either the radiation boost field or for partial breast irradiation, if indicated.", "validation_result": "Supported", "page_location": "Page 4, Locoregional treatment, Surgery", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Asia-Pacific. Cancer Australia\u00b2\u2070 - Proposes to consider placing a clip or marker at the completion of core biopsy and when multiple lesions are biopsied.", "reference_no": "20", "reference": "Interpretation of the evidence. Cancer Australia. Published 2017.15. https://www.canceraustralia.gov.au/resources/position-statements/ position-statement-use-\ufb01ne- needle-aspiration- and-core- biopsy-breastbreastscreen-australia-program/interpretation -evidence.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 20.Interpretation of the evidence..pdf: Consideration should be given to placing a clip or a marker at the completion of the core biopsy, particularly in situations where a substantial proportion of the lesion may be removed by the biopsy process.|Lesion marker clips are also used when multiple lesions are biopsied, and to assist multimodality lesion correlation.", "validation_result": "Supported", "page_location": "Page 2, under \"Core biopsy \u2013 Advantages and disadvantages\"", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Asia-Pacific. Breast Imaging Society of India\u00b2\u00b9 - Specifies that a radio-opaque marker clip should be deployed at the site of the biopsy. The deployment of a marker clip is also recommended prior to NAC.", "reference_no": "21", "reference": "Suma Chakrabarthi, Shikha Panwar, Singh T, et al. Best Practice Guidelines for Breast Imaging, Breast Imaging Society, India: Part\u20142. Annals of the National Academy of Medical Sciences (India). 2022;58(02):069-077 Abbreviations: APAC - Asia-Paci\ufb01c; NAC - Neoadjuvant Chemotherapy; BCS - Breast-Conserving Surgery; MRI - Magnetic Resonance Imaging; US - Ultrasound; MG - Mammography; LN - Lymph Node; TAS - Tailored Axillary Surgery; BRCA - Breast Cancer; FNA - Fine Needle Aspiration; NCB - Needle Core Biopsy; VANCB - Vacuum-Assisted Needle Core Biopsy; USA - United States of America", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 21.Suma Chakrabarthi,2022.pdf: A post-procedure radio-opaque marker clip should be deployed at the site of the biopsy for microcalcifications, asymmetries, as well as small masses considering the fact that these lesions may be harder to visualize following a stereotactic VAB.|Prior to neo-adjuvant chemotherapy. The deployment of a marker clip is recommended as some malignancies may respond very well to neoadjuvant treatment and almost disappear following treatment.", "validation_result": "Supported", "page_location": "Page 3, Post-Procedure Requirement | Page 4, Marker Clip Deployment", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}], "created_at": "2026-02-03T14:29:04.646381"}